Suppressive effect of curcumin on apoptosis of articular chondrocytes via regulation on NF-κB pathway and NLRP3 inflammasome
- PMID: 39897107
- PMCID: PMC11785841
- DOI: 10.1007/s10616-024-00695-2
Suppressive effect of curcumin on apoptosis of articular chondrocytes via regulation on NF-κB pathway and NLRP3 inflammasome
Abstract
Our study probed into how curcumin modulates NF-κB pathway to regulate articular chondrocytes. ATDC5 cells were exposed to varying concentrations of curcumin (0, 10, 20, 50, or 100 μM) for 48 h, followed by an assessment of curcumin's cytotoxicity. Cells were also treated with 10 ng/ml IL-1β, curcumin, 5 μg/L NF-κB inhibitor (PDTC), and 5 μM NLRP3 inflammasome inducer (nigericin) for 48 h, before cell viability, apoptosis, NF-κB pathway-related proteins, NLRP3 inflammasome-related proteins and inflammatory cytokines were detected. IL-1β treatment notably diminished chondrocyte viability and increased apoptosis, evidenced by elevated level of Bax and cleaved caspase-3, and reduced level of Bcl2, while such expression patterns were reversed by curcumin treatment in a concentration-dependent fashion. Additionally, NF-κB pathway and NLRP3 inflammasome in chondrocytes were activated by IL-1β treatment, but can also be suppressed following curcumin intervention. Furthermore, inhibition of NF-κB pathway curtailed the NLRP3 inflammasome activation and chondrocyte apoptosis, while activation of the NLRP3 inflammasome partially reversed the protective impacts of curcumin against chondrocyte apoptosis. Curcumin inhibits NF-κB pathway, thereby preventing the NLRP3 inflammasome activation and ameliorating IL-1β-induced apoptosis in articular chondrocytes.
Keywords: Apoptosis; Chondrocytes; Curcumin; NF-κB pathway; NLRP3 inflammasome.
© The Author(s), under exclusive licence to Springer Nature B.V. 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestsThe authors declare no competing interests.
Similar articles
-
Rutaecarpine Attenuates Monosodium Urate Crystal-Induced Gouty Inflammation via Inhibition of TNFR-MAPK/NF-κB and NLRP3 Inflammasome Signaling Pathways.Chin J Integr Med. 2025 Jul;31(7):590-599. doi: 10.1007/s11655-025-4204-3. Epub 2025 May 8. Chin J Integr Med. 2025. PMID: 40338445
-
Reduced NF-κB/NLRP3/IL-18 signaling increases the protective effect of L-glutamine against LPS-induced retinal inflammation in mice: Utilization of network pharmacology and experimental validation.Eur J Pharmacol. 2025 Sep 5;1002:177840. doi: 10.1016/j.ejphar.2025.177840. Epub 2025 Jun 11. Eur J Pharmacol. 2025. PMID: 40513937
-
Zhongfeng Xingnao Liquid Ameliorated the Early Impairment of Intracerebral Hemorrhage by Inhibiting NF-κB/NLRP3 Axis in Rats.J Inflamm Res. 2025 Jul 3;18:8805-8819. doi: 10.2147/JIR.S528358. eCollection 2025. J Inflamm Res. 2025. PMID: 40631046 Free PMC article.
-
Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy.Inflammopharmacology. 2025 May;33(5):2231-2262. doi: 10.1007/s10787-025-01729-7. Epub 2025 Apr 9. Inflammopharmacology. 2025. PMID: 40205269 Free PMC article. Review.
-
New Insights on the Potential Role of Pyroptosis in Parkinson's Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics.Mol Neurobiol. 2025 Jul;62(7):9365-9384. doi: 10.1007/s12035-025-04818-4. Epub 2025 Mar 18. Mol Neurobiol. 2025. PMID: 40100493 Review.
References
-
- An X, Zhou F, Li G, Wei Y, Huang B, Li M, Zhang Q, Xu K, Zhao RC, Su J (2024) Cyaonoside a-loaded composite hydrogel microspheres to treat osteoarthritis by relieving chondrocyte inflammation. J Mater Chem B 12:4148–4161 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials